Article Details

Amyris, ImmunityBio Higher After Completing Covid Vaccine JV - MarketWatch

Retrieved on: 2022-01-03 17:53:47

Tags for this article:

Click the tags to see associated articles and topics

Amyris, ImmunityBio Higher After Completing Covid Vaccine JV - MarketWatch. View article details on hiswai:

Excerpt

RNA technology platform and Amyris' adjuvant technology," said ImmunityBio Executive Chairman and Global Chief Scientific and Medical Officer ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up